Ulcerative Colitis and Acute Severe Ulcerative Colitis Patients Are Overlooked in Infliximab Population Pharmacokinetic Models: Results from a Comprehensive Review

por Démaris, Alix, Widigson, Ella S. K., Ilvemark, Johan F. K. F., Steenholdt, Casper, Seidelin, Jakob B., Huisinga, Wilhelm, Michelet, Robin, Aulin, Linda B. S., Kloft, Charlotte
Publicado 2022

Infliximab clearance decreases in the second and third trimesters of pregnancy in inflammatory bowel disease

por Grišić, Ana‐Marija, Dorn‐Rasmussen, Maria, Ungar, Bella, Brynskov, Jørn, Ilvemark, Johan F. K. F., Bolstad, Nils, Warren, David J., Ainsworth, Mark A., Huisinga, Wilhelm, Ben‐Horin, Shomron, Kloft, Charlotte, Steenholdt, Casper
Publicado 2021

Defining Transabdominal Intestinal Ultrasound Treatment Response and Remission in Inflammatory Bowel Disease: Systematic Review and Expert Consensus Statement

por Ilvemark, Johan F K F, Hansen, Tawnya, Goodsall, Thomas M, Seidelin, Jakob B, Al- Farhan, Heba, Allocca, Mariangela, Begun, Jakob, Bryant, Robert V, Carter, Dan, Christensen, Britt, Dubinsky, Marla C, Gecse, Krisztina B, Kucharzik, Torsten, Lu, Cathy, Maaser, Christian, Maconi, Giovanni, Nylund, Kim, Palmela, Carolina, Wilson, Stephanie R, Novak, Kerri, Wilkens, Rune
Publicado 2021